Toxicities and costs of placing prophylactic and reactive percutaneous gastrostomy tubes in patients with locally advanced head and neck cancers treated with chemoradiotherapy

Head Neck. 2014 Aug;36(8):1155-61. doi: 10.1002/hed.23426. Epub 2013 Nov 27.

Abstract

Background: We compared dependence rates, complications, toxicities, and costs associated with prophylactic versus reactive percutaneous endoscopic gastrostomy (PEG) tube placement.

Methods: One hundred ninety-three patients with locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy were retrospectively reviewed.

Results: The 1-year and 2-year actuarial PEG tube dependence rate of the entire cohort was 24% and 13%, respectively. There was no difference in the PEG tube dependence rates between those placed prophylactically versus reactively. Patients who received a PEG tube reactively had a significantly higher stricture rate (p = .03) and aspiration rate (p < .001) compared to the prophylactic group. There were significantly fewer hospitalizations in the prophylactic group compared to the reactive group (p = .003). When accounting for both PEG placement and hospitalizations, the prophylactic approach was found to be more cost effective.

Conclusion: PEG tubes placed prophylactically were associated with lower rates of strictures, aspirations, hospitalizations, and costs compared to those placed reactively.

Keywords: percutaneous endoscopic gastrostomy (PEG) tube; prophylactic PEG tube; reactive PEG tube.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell / economics
  • Carcinoma, Squamous Cell / therapy*
  • Chemoradiotherapy / methods*
  • Costs and Cost Analysis
  • Deglutition Disorders / economics
  • Deglutition Disorders / prevention & control*
  • Endoscopy, Gastrointestinal
  • Enteral Nutrition / instrumentation*
  • Female
  • Gastrostomy / economics
  • Gastrostomy / methods*
  • Head and Neck Neoplasms / economics
  • Head and Neck Neoplasms / therapy*
  • Hospitalization
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Squamous Cell Carcinoma of Head and Neck
  • Treatment Outcome